These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11167966)

  • 21. Sucralfate and methylprednisolone enemas in active ulcerative colitis: a prospective, single-blind study.
    Wright JP; Winter TA; Candy S; Marks IS
    Dig Dis Sci; 1999 Sep; 44(9):1899-901. PubMed ID: 10505732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical treatment options for peristomal pyoderma gangrenosum.
    Vujnovich A
    Br J Nurs; 2005 Sep 8-21; 14(16):S4-8. PubMed ID: 16215501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical application of a beclometasone steroid inhaler for treatment of stoma inflammation.
    Boland J; Brooks D
    Palliat Med; 2012 Dec; 26(8):1055-6. PubMed ID: 22573469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Giant refractory solitary rectal ulcer syndrome treated with topical sucralfate.
    da Fonseca LM; Souza Fde L; Arantes V; da Silva RG
    Int J Colorectal Dis; 2010 Aug; 25(8):1025-6. PubMed ID: 20174810
    [No Abstract]   [Full Text] [Related]  

  • 25. Care and treatment of peristomal gangrenous pyoderma. A study of three cases.
    Julve-Herraiz L; Villalba-Ferrer F; García-Coret MJ; García-Costa B
    Enferm Clin (Engl Ed); 2021; 31(2):120-125. PubMed ID: 33541774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical tacrolimus in the management of peristomal pyoderma gangrenosum.
    Lyon CC; Stapleton M; Smith AJ; Mendelsohn S; Beck MH; Griffiths CE
    J Dermatolog Treat; 2001 Mar; 12(1):13-7. PubMed ID: 12171681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of peristomal pyoderma gangrenosum.
    Poritz LS; Lebo MA; Bobb AD; Ardell CM; Koltun WA
    J Am Coll Surg; 2008 Feb; 206(2):311-5. PubMed ID: 18222385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrolimus ointment 0.1% for the treatment of peristomal skin disease: 3 case reports.
    Wells GL; Brown J; Manganiello WD; Chapman MS
    Cutis; 2006 Oct; 78(4):258-60. PubMed ID: 17121062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adhesion problems of stoma accessories due to peristomal dermatitis].
    Houwing RH; Oosterlaar S
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33560607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Topical Sucralfate in the Management of Pressure Ulcer in Hospitalized Patients: A Prospective, Randomized, Placebo-Controlled Trial.
    Ala S; Saeedi M; Gholipour A; Ahmadi M; Asoodeh A; Shiva A
    Am J Ther; 2019; 26(1):e5-e11. PubMed ID: 29642075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sucralfate versus placebo in the treatment of abdominal wound abscesses].
    Andersen J; Dahlin J; Bruun E
    Ugeskr Laeger; 1993 Mar; 155(9):647-9. PubMed ID: 8447035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common peristomal skin problems and potential treatment options.
    Burch J; Sica J
    Br J Nurs; 2008 Sep 25-Oct 8; 17(17):S4, S6, S8 passim. PubMed ID: 18948858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid sucralfate in the management of aphthous ulcers.
    Lewis JD
    Am Fam Physician; 2001 Sep; 64(5):737. PubMed ID: 11563565
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical governance for ostomates at risk of peristomal skin complications.
    White P; Evans M
    Br J Nurs; 2019 Sep; 28(16):S24-S32. PubMed ID: 31518526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of duodenal ulcer healing in sucralfate treated patients.
    Haq SA; Rahman MT; Hasan M; Khan AK
    Bangladesh Med Res Counc Bull; 1996 Aug; 22(2):65-9. PubMed ID: 9103658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Peristomal Skin Complications Reported by WOC Nurses.
    Ratliff CR
    J Wound Ostomy Continence Nurs; 2010; 37(5):505-10. PubMed ID: 20736859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recurrence of reflux esophagitis can be prevented with maintenance therapy with sucralfate].
    Tytgat GN; Koelz HR; Vosmaer GD
    Ned Tijdschr Geneeskd; 1995 Nov; 139(47):2432-7. PubMed ID: 8524425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of sucralfate, lansoprazole, and cimetidine on the delayed healing by hydrocortisone sodium phosphate of chronic gastric ulcers in the rat.
    Kuwayama H; Matsuo Y; Eastwood GL
    Am J Med; 1991 Aug; 91(2A):15S-19S. PubMed ID: 1882902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Care of patients with peristomal skin complications.
    Burch J
    Nurs Stand; 2014 May; 28(37):51-7. PubMed ID: 24823592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical sucralfate for prevention of peristomal wound reaction related to percutaneous endoscopic gastrostomy in children: A randomized controlled trial.
    Saneian H; Mehrannia A; Sabzghabaee AM; Feizi A; Famouri F; Abtahi-Naeini B
    Dermatol Ther; 2022 Oct; 35(10):e15729. PubMed ID: 35871473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.